[Safety and efficacy of intra-arterial tirofiban infusion in patients with acute cardiogenic cerebral embolism undergoing endovascular reperfusion therapy].

Lin, T; Du, J; Liu, L; Wu, Z; Kong, X K; Duan, W B; Du, B; Yu, Y J; Wen, W L; Cai, Y L

Lin, T; Du, J; Liu, L; Wu, Z; Kong, X K; Duan, W B; Du, B; Yu, Y J; Wen, W L; Cai, Y L.

Afiliación

Lin T; Department of Neurology, Strategic Support Force Medical Center, Beijing 100101, China.
Du J; Department of Neurology, Strategic Support Force Medical Center, Beijing 100101, China.
Liu L; Department of Neurology, Strategic Support Force Medical Center, Beijing 100101, China.
Wu Z; Department of Neurology, Strategic Support Force Medical Center, Beijing 100101, China.
Kong XK; Department of Neurology, Strategic Support Force Medical Center, Beijing 100101, China.
Duan WB; Department of Neurology, Strategic Support Force Medical Center, Beijing 100101, China.
Du B; Department of Neurology, Strategic Support Force Medical Center, Beijing 100101, China.
Yu YJ; Department of Neurology, Strategic Support Force Medical Center, Beijing 100101, China.
Wen WL; Department of Neurology, Strategic Support Force Medical Center, Beijing 100101, China.
Cai YL; Department of Neurology, Strategic Support Force Medical Center, Beijing 100101, China.

Zhonghua Nei Ke Za Zhi ; 61(4): 397-402, 2022 Apr 01.

Article en Zh | MEDLINE | ID: mdl-35340186

Asunto(s)

Embolia Intracraneal; Accidente Cerebrovascular; Humanos; Reperfusión; Estudios Retrospectivos; Accidente Cerebrovascular/terapia; Tirofibán/uso terapéutico; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Accidente Cerebrovascular / Embolia Intracraneal Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: Zh Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google